ArticleNPJ breast cancer2025

Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial.

Joan Albanell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.